Home › Studies › PRJEB63570
PRJEB63570 ERP148718

Klebsiella transmission on a Malawi neonatal nursery ward

Klebsiella_transmission_and_immunity_on_Chatinkha_nursery__Neo_TRACK_

A longitudinal cohort study of 928 samples from Chatinkha nursery in Malawi, investigating Klebsiella pneumoniae transmission and immunity to inform vaccine, antibiotic, and infection control strategies. machine-written summary

928 samples · 1,592 runs · MW · Infant / toddler · 2024 · 3.28 Gbp / sample

Sources
✓Sequence archive 1,973✓Abstract / description 928–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,973 sample values (collection date, country, timepoint)
✓ Abstract / description928 sample values (location site)
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet · share metadata
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 country
Age
unknown928
Country
MW928
Body site
unknown928
Collected 2021–2027
2021: 15 samples2022: 822 samples2023: 87 samples2024: 1 samples2025: 1 samples2026: 1 samples2027: 1 samples20212027
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 1 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 2 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 62 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 863 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.10 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolvedhospital ward — not resolved

Schedule stated by the source: “Serial sampling labeled D1 through D12, suggesting repeated daily sampling of neonates on the nursery ward.”.

Study tracks Klebsiella transmission among neonates on Chatinkha nursery ward, Malawi; no individual family/sibling links given in metadata..

How longitudinal and relatedness information is derived

Community composition
Acinetobacter 42.4%Escherichia 11.5%Staphylococcus 11.1%Klebsiella 10.9%Enterobacter 9.0%Enterococcus_B 3.0%Bacillus 1.0%Pseudomonas 0.8%Macrococcoides 0.8%ECMA0423 0.8%Mammaliicoccus 0.7%Stenotrophomonas 0.5%not assigned to a genus 2.2%other genera 5.3%

Genera, mean relative abundance over 828 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country928 100%928
health_condition0 0%
subject_id0 0%
collection_date928 100%928
detailed_location928 100%
location_site928 100%928
timepoint_label117 13%117
Papers (2)
  • High ward-level and within-sample diversity of Klebsiella pneumoniae on a Malawian neonatal unit revealed by single colony whole genome sequencing and post-enrichment metagenomics curated
  • Extended-Spectrum Beta-Lactamase Klebsiella pneumoniae on a Malawian neonatal unit is amplified by neonates and transmitted by maternal hands, cots and ward surfaces curated
Details
Archive description

As treatment of KPn has become increasingly difficult, attention has turned to methods of prevention instead. One such strategy would be a KPn vaccine delivered to mothers to give their infants passive immunity in the first months of life, whilst they are most vulnerable. There is currently no vaccine against KPn, and it is not known which targets would offer protection. However, developing a vaccine based on surface exposed structures such as the O-antigen is most likely to be effective. A second potential method would be to identify infants most at risk of KPn infection and managing them with alternative first-line antibiotic therapy such as carbapenems, rather than waiting for the culture to become positive, as delay in starting therapy is dangerous. Lastly, we should identify the most important areas for targeting of infection prevention and control (IPC) measures based on the important modes of transmission. For each of these potential interventions (an O-antigen vaccine, empirical carbapenem therapy for high-risk infants and IPC strategies) whether they will work and how they should be deployed is uncertain due to a limited knowledge base. We see quality improvement in all three areas as being essential to improving outcomes and this study will improve the knowledge base in these three areas so that interventions aimed at prevention can be developed in an evidence-based manner.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of infant / toddler and adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage verdict include”
  • body site external_curation.infant_catalog · “infant triage verdict include (gut/stool scope)”
  • life stage external_curation.infant_catalog · “infant triage verdict include (0-3 y scope)”
  • life stage study.description · “to give their infants passive immunity in”
  • life stage study.description · “vaccine delivered to mothers to give their”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA114246621collection_date2022-12-08R10.85biosample.attribute:collection_date2022-12-08
SAMEA114246621countryMWR10.90biosample_attrMalawi
SAMEA114246621location_siteChatinkha nurseryR40.40ena.study_titleKlebsiella_transmission_and_immunity_on_Chatinkha_nursery
SAMEA114246843timepoint_labelD10R10.70run.library_nameSQPP-6656-B:D10
Sequencing

1,592 runs over 928 samples · mean 2.53 Gbp per run (median 3.28 Gbp, total 4,020.72 Gbp; 1,592 runs with a base count) · layout PAIRED 1,592 · platform ILLUMINA 1,592 · models Illumina NovaSeq 6000 (1,592) · 89% of runs with a Sandpiper profile · first public 2024-09-24 – 2024-11-27

Authors (15)

Pearse O first · Zuza A · Lester R · Mangochi H · Siyabu P · Tewesa E · Edwards T · Thomson NR · Feasey NA · Kawaza K · Jewell C · Musicha P · Cornick J · Feasey N · Heinz E last

Help complete this project

3 of the 4 core fields are below 50% coverage: age_category, health_condition, subject_id. Share metadata

Downloads

PRJEB63570.csv.gz (24.3 KB) · parquet (108.5 KB) — all 928 samples, every field with route and confidence · PRJEB63570_determinations.csv.gz (15.3 KB) — 2,901 evidence rows

Samples (928 · every field this project has values for · hover a cell for its source)
Loading the sample table…